192 related articles for article (PubMed ID: 32843547)
1. Kaposi's Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma.
Manzano M; Günther T; Ju H; Nicholas J; Bartom ET; Grundhoff A; Gottwein E
mBio; 2020 Aug; 11(4):. PubMed ID: 32843547
[TBL] [Abstract][Full Text] [Related]
2. Global epigenomic analysis of KSHV-infected primary effusion lymphoma identifies functional
Park A; Oh S; Jung KL; Choi UY; Lee HR; Rosenfeld MG; Jung JU
Proc Natl Acad Sci U S A; 2020 Sep; 117(35):21618-21627. PubMed ID: 32817485
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies.
Paul AG; Chandran B; Sharma-Walia N
Transl Res; 2013 Aug; 162(2):77-92. PubMed ID: 23567332
[TBL] [Abstract][Full Text] [Related]
4. Druggable host gene dependencies in primary effusion lymphoma.
Kuehnle N; Gottwein E
Curr Opin Virol; 2022 Oct; 56():101270. PubMed ID: 36182745
[TBL] [Abstract][Full Text] [Related]
5. CADM1 is essential for KSHV-encoded vGPCR-and vFLIP-mediated chronic NF-κB activation.
Hunte R; Alonso P; Thomas R; Bazile CA; Ramos JC; van der Weyden L; Dominguez-Bendala J; Khan WN; Shembade N
PLoS Pathog; 2018 Apr; 14(4):e1006968. PubMed ID: 29698475
[TBL] [Abstract][Full Text] [Related]
6. The Kaposi's Sarcoma-associated Herpesvirus-encoded vIRF-3 Inhibits Cellular IRF-5.
Wies E; Hahn AS; Schmidt K; Viebahn C; Rohland N; Lux A; Schellhorn T; Holzer A; Jung JU; Neipel F
J Biol Chem; 2009 Mar; 284(13):8525-38. PubMed ID: 19129183
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9 ablating viral microRNA promotes lytic reactivation of Kaposi's sarcoma-associated herpesvirus.
Liang Z; Qin Z; Riker AI; Xi Y
Biochem Biophys Res Commun; 2020 Dec; 533(4):1400-1405. PubMed ID: 33092788
[TBL] [Abstract][Full Text] [Related]
8. Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors.
Tolani B; Gopalakrishnan R; Punj V; Matta H; Chaudhary PM
Oncogene; 2014 May; 33(22):2928-37. PubMed ID: 23792448
[TBL] [Abstract][Full Text] [Related]
9. Kaposi's sarcoma-associated herpesvirus at 27.
Gaglia MM
Tumour Virus Res; 2021 Dec; 12():200223. PubMed ID: 34153523
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 Receptor-Associated Kinase (IRAK) Signaling in Kaposi Sarcoma-Associated Herpesvirus-Induced Primary Effusion Lymphoma.
Seltzer J; Moorad R; Schifano JM; Landis JT; Dittmer DP
J Virol; 2020 May; 94(10):. PubMed ID: 32161170
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of interferon regulatory factor 7 (IRF7)-mediated interferon signal transduction by the Kaposi's sarcoma-associated herpesvirus viral IRF homolog vIRF3.
Joo CH; Shin YC; Gack M; Wu L; Levy D; Jung JU
J Virol; 2007 Aug; 81(15):8282-92. PubMed ID: 17522209
[TBL] [Abstract][Full Text] [Related]
12. Enhancer-promoter activation by the Kaposi sarcoma-associated herpesvirus episome maintenance protein LANA.
Ye X; Guerin LN; Chen Z; Rajendren S; Dunker W; Zhao Y; Zhang R; Hodges E; Karijolich J
Cell Rep; 2024 Mar; 43(3):113888. PubMed ID: 38416644
[TBL] [Abstract][Full Text] [Related]
13. Reversible switching of primary cells between normal and malignant state by oncogenic virus KSHV and CRISPR/Cas9-mediated targeting of a major viral latent protein.
Ju E; Li T; Ramos da Silva S; Markazi A; Gao SJ
J Med Virol; 2021 Aug; 93(8):5065-5075. PubMed ID: 33942339
[TBL] [Abstract][Full Text] [Related]
14. The chromatin modification by SUMO-2/3 but not SUMO-1 prevents the epigenetic activation of key immune-related genes during Kaposi's sarcoma associated herpesvirus reactivation.
Chang PC; Cheng CY; Campbell M; Yang YC; Hsu HW; Chang TY; Chu CH; Lee YW; Hung CL; Lai SM; Tepper CG; Hsieh WP; Wang HW; Tang CY; Wang WC; Kung HJ
BMC Genomics; 2013 Nov; 14(1):824. PubMed ID: 24267727
[TBL] [Abstract][Full Text] [Related]
15. Developing new ceramide analogs and identifying novel sphingolipid-controlled genes against a virus-associated lymphoma.
Chen J; Goyal N; Dai L; Lin Z; Del Valle L; Zabaleta J; Liu J; Post SR; Foroozesh M; Qin Z
Blood; 2020 Nov; 136(19):2175-2187. PubMed ID: 32518949
[TBL] [Abstract][Full Text] [Related]
16. Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders.
Du MQ; Bacon CM; Isaacson PG
J Clin Pathol; 2007 Dec; 60(12):1350-7. PubMed ID: 18042691
[TBL] [Abstract][Full Text] [Related]
17. Echinomycin as a promising therapeutic agent against KSHV-related malignancies.
Chen J; Lin Z; Song J; Plaisance-Bonstaff K; James J; Mu S; Post SR; Dai L; Qin Z
J Hematol Oncol; 2023 May; 16(1):48. PubMed ID: 37143124
[TBL] [Abstract][Full Text] [Related]
18. Internal ribosome entry site regulates translation of Kaposi's sarcoma-associated herpesvirus FLICE inhibitory protein.
Low W; Harries M; Ye H; Du MQ; Boshoff C; Collins M
J Virol; 2001 Mar; 75(6):2938-45. PubMed ID: 11222719
[TBL] [Abstract][Full Text] [Related]
19. SPIB and BATF provide alternate determinants of IRF4 occupancy in diffuse large B-cell lymphoma linked to disease heterogeneity.
Care MA; Cocco M; Laye JP; Barnes N; Huang Y; Wang M; Barrans S; Du M; Jack A; Westhead DR; Doody GM; Tooze RM
Nucleic Acids Res; 2014 Jul; 42(12):7591-610. PubMed ID: 24875472
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of NEK2 Promotes Chemosensitivity and Reduces KSHV-positive Primary Effusion Lymphoma Burden.
White MC; Wong JP; Damania B
Cancer Res Commun; 2024 Apr; 4(4):1024-1040. PubMed ID: 38592451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
